Health Care & Life Sciences » Pharmaceuticals | Hutchison China MediTech Ltd.

Hutchison China MediTech Ltd.

Hutchison China MediTech Ltd.
Stock Exchange London Stock Exchange
EPS
GBP0.08
Market Cap
GBP2.45 B
Shares Outstanding
666.58 M
Public Float
21.83 M
Hutchison China MediTech Ltd. ADR
Stock Exchange NASDAQ Stock Market
EPS
$0.06
Market Cap
$30.09 B
Shares Outstanding
133.32 M
Public Float
-

Profile

Address
Cheung Kong Center
Hong Kong
Hong Kong
Employees -
Website http://www.chi-med.com
Updated 07/08/2019
Hutchison China MediTech Ltd. is a holding company, which engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products. It operates through the Innovation Platform and Commercial Platform segments. The Innovation Platform segment relates to research and development of innovative therapeutics in oncology and autoimmune diseases.

Financials

View All

Chi Keung To
Chairman
Christian Hogg
Chief Executive Officer & Executive Director